प्रेडनिसोन के इंटरैक्शन

Use of a LABA, including arformoterol tartrate inhalation solution, without an inhaled corticosteroid is contraindicated in patients with asthma. (आरफॉर्मोटेरोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

If differentiation syndrome is suspected, immediately initiate high-dose corticosteroids and hemodynamic monitoring until resolution. (आर्सेनिक ट्राइऑक्साइड लेबल, बॉक्स्ड चेतावनी)

Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. (इन्फ्लिक्सिमैब लेबल, बॉक्स्ड चेतावनी)

Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. (उपाडासिटिनिब लेबल, बॉक्स्ड चेतावनी)

Withhold INLYTA and avelumab or pembrolizumab, initiate corticosteroid therapy as needed, and/or permanently discontinue the combination for severe or life-threatening hepatotoxicity. (एक्सिटिनिब लेबल, चेतावनियां और सावधानियां)

Coadministration of fluticasone propionate and REYATAZ with ritonavir is not recommended unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects [see Warnings and Precautions (5.1) ] . (एटाज़ानाविर लेबल, दवाओं के इंटरैक्शन)

Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. (एटैनरसेप्ट लेबल, बॉक्स्ड चेतावनी)

Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. (एडालिमुमैब लेबल, बॉक्स्ड चेतावनी)

…Antihistamines Thyroid hormones Diuretics Cardiac glycosides, such as digitalis glycosides Quinidine Drugs potentiating hypokalemic effects of epinephrine • Potassium depleting diuretics • Corticosteroids • Theophylline Epinephrine should not be used to counteract circulatory collapse or hypotension caused by phenothiazines, as a reversal of the pressor effects of epinephrine… (एड्रेनालिन लेबल, दवाओं के इंटरैक्शन)

At the primary analysis, increased incidences of fractures (28.6% vs 11.4%) and deaths (38.5% vs 35.5%) have been observed in patients who received abiraterone acetate plus a corticosteroid in combination with radium Ra 223 dichloride compared to patients who received placebo in combination with abiraterone acetate plus a corticosteroid. (एबिराटेरोन लेबल, चेतावनियां और सावधानियां)

…(5.7) , Drug Interactions (7) , and Clinical Pharmacology (12.3) ]: Anticonvulsants: carbamazepine, oxcarbazepine, phenobarbital, phenytoin Antimycobacterials: rifampin, rifapentine Glucocorticoid (systemic): dexamethasone (more than a single-dose) Herbal Products: St John's wort ( Hypericum perforatum ) Proton Pump Inhibitors: e.g., dexlansoprazole, esomeprazole,… (एमट्रिसिटाबिन, रिल्पिविरिन और टेनोफोविर लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Fluticasone: Coadministration of fluticasone propionate and ketoconazole is not recommended unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects. (कीटोकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. (टोफासिटिनिब लेबल, बॉक्स्ड चेतावनी)

Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. (टोसिलिज़ुमैब लेबल, बॉक्स्ड चेतावनी)

At first signs or symptoms of this syndrome, immediately initiate high-dose corticosteroid therapy and hemodynamic monitoring until resolution of signs and symptoms. (ट्रेटिनोइन लेबल, बॉक्स्ड चेतावनी)

Two of the four cases were life-threatening and resolved without treatment or with medication (corticosteroids). (ट्रैंडोलाप्रिल लेबल, चेतावनियां)

Severe hypersensitivity reactions characterized by generalized rash/erythema, hypotension and/or bronchospasm, or fatal anaphylaxis, have been reported in patients premedicated with 3 days of corticosteroids. (डोसेटैक्सेल लेबल, चेतावनियां और सावधानियां)

Therefore, use of prednisone to prevent nevirapine-associated rash is not recommended. (नेविरापिन लेबल, चेतावनियां और सावधानियां)

Use of a LABA, including formoterol fumarate inhalation solution, without an inhaled corticosteroid is contraindicated in patients with asthma [see Warnings and Precautions (5.1) ]. (फॉर्मोटेरोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Coadministration of fluticasone and fosamprenavir calcium/ritonavir is not recommended unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects. (फोसएम्प्रेनाविर लेबल, दवाओं के इंटरैक्शन)

Most patients with rheumatoid arthritis who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. (बैरिसिटिनिब लेबल, बॉक्स्ड चेतावनी)

If shock, severe trauma or infection occurs or develops, temporarily discontinue LYSODREN and administer exogenous steroids. (माइटोटेन लेबल, बॉक्स्ड चेतावनी)

WARNING: TERMINATION OF PREGNANCY Mifepristone is a potent antagonist of progesterone and cortisol via the progesterone and glucocorticoid (GR-II) receptors, respectively. (मिफेप्रिस्टोन लेबल, बॉक्स्ड चेतावनी)

None of the cases were considered life-threatening and all resolved either without treatment or with medication (antihistamines or glucocorticoids). (मोएक्सिप्रिल लेबल, चेतावनियां)

• use of a long-acting beta 2 -adrenergic agonist (LABA), including vilanterol, one of the active ingredients in Umeclidinium and Vilanterol ELLIPTA, without an inhaled corticosteroid (ICS), in patients with asthma [see Warnings and Precautions ( 5.1 )] . (यूमेक्लिडिनियम और विलैंटेरोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Antimycobacterials Rifampin Rifapentine Glucocorticoid (systemic) Dexamethasone (more than a single-dose treatment) Herbal Products St. (रिल्पिविरिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Moreover, cholesterol and other products of the cholesterol biosynthesis pathway are essential components for fetal development, including synthesis of steroids and cell membranes. (लोवास्टेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

In a multicenter clinical study, de novo renal transplant patients treated with sirolimus, mycophenolate mofetil (MMF), steroids, and an IL-2 receptor antagonist had significantly higher acute rejection rates and numerically higher death rates compared to patients treated with cyclosporine, MMF, steroids, and IL-2 receptor antagonist. (सिरोलिमस लेबल, चेतावनियां और सावधानियां)

WARNING: ASTHMA-RELATED DEATH Long-acting beta 2 -adrenergic agonists (LABA), such as salmeterol, the active ingredient in SEREVENT DISKUS, as monotherapy (without inhaled corticosteroids [ICS]) increase the risk of asthma-related death. (सैल्मेटेरोल लेबल, बॉक्स्ड चेतावनी)

Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (सोमाट्रोपिन लेबल, दवाओं के इंटरैक्शन)

Patients receiving concomitant corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs) or anti-angiogenic agents, or patients with increasing age or who have an underlying history of gastrointestinal ulceration, underlying diverticular disease or bowel metastases may be at increased risk of perforation. (अफाटिनिब लेबल, चेतावनियां और सावधानियां)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Oral hydration, recumbency, intravenous normal saline, and/or parenteral corticosteroids have been used to treat postural hypotension. (आइवरमेक्टिन लेबल, चेतावनियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antitubercular Drugs Serum concentrations of isoniazid may be decreased. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Anticoagulant agents: May enhance or diminish anticoagulant effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

…osteonecrosis of the jaw include invasive dental procedures (e.g., tooth extraction, dental implants, boney surgery), diagnosis of cancer, concomitant therapies (e.g., chemotherapy, corticosteroids, angiogenesis inhibitors), poor oral hygiene, and co-morbid disorders (e.g., periodontal and/or other pre-existing dental disease, anemia, coagulopathy, infection, ill-fitting… (इबैंड्रोनेट लेबल, चेतावनियां और सावधानियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Sympathomimetics, Methylxanthines, Steroids In clinical studies, concurrent administration of aclidinium bromide and other drugs commonly used in the treatment of COPD including sympathomimetics (short-acting beta 2 agonists), methylxanthines, and oral and inhaled steroids showed no increases in adverse drug reactions. (एक्लिडिनियम लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

In a detailed case report, 4 documented lymphopenia, diminished IgG and IgM levels, CMV infection, and a decreased thymic shadow were noted in an infant born to a mother receiving 150 mg azathioprine and 30 mg prednisone daily throughout pregnancy. (एज़ाथियोप्रिन लेबल, चेतावनियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Anticoagulant agents: May enhance or diminish anticoagulant effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Anticoagulant agents: May enhance or diminish anticoagulant effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Anticoagulant agents: May enhance or diminish anticoagulant effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inducers (e.g., Barbiturates, Phenytoin, Carbamazepine, and Rifampin) Drugs such as barbiturates, phenytoin, ephedrine, and rifampin, which induce hepatic microsomal drug metabolizing enzyme activity may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Corticosteroids and Corticotropin (ACTH) Concurrent use of corticosteroids and ACTH may potentiate hypokalemia, which could predispose the patient to cardiac dysfunction. (एम्फोटेरिसिन B लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Patients receiving concomitant anti-angiogenic agents, corticosteroids, NSAIDs, or taxane-based chemotherapy, or who have prior history of peptic ulceration or diverticular disease may be at increased risk of perforation [see Adverse Reactions (6.1 , 6.2) ]. (एर्लोटिनिब लेबल, चेतावनियां और सावधानियां)

Patients who experience these effects, even without respiratory distress, require prolonged observation and appropriate monitoring measures since treatment with antihistamines and corticosteroids may not be sufficient to prevent respiratory involvement. (एलिस्किरेन लेबल, चेतावनियां और सावधानियां)

…osteonecrosis of the jaw include invasive dental procedures (e.g., tooth extraction, dental implants, boney surgery), diagnosis of cancer, concomitant therapies (e.g., chemotherapy, corticosteroids, angiogenesis inhibitors), poor oral hygiene, and co-morbid disorders (e.g., periodontal and/or other pre-existing dental disease, anemia, coagulopathy, infection, ill-fitting… (एलेंड्रोनेट लेबल, चेतावनियां और सावधानियां)

Although other risk factors were present in some cases (such as corticosteroid use, exposure to radiation), a possible risk attributable to treatment with ivacaftor cannot be excluded. (एलेक्साकैफ्टर, टेज़ाकैफ्टर और आइवाकैफ्टर लेबल, चेतावनियां और सावधानियां)

Institute appropriate medical management (e.g., glucocorticoids, epinephrine, meperidine) for infusion-related reactions as needed [see Dosage and Administration (2.2) ] . (एलेमटुज़ुमैब लेबल, चेतावनियां और सावधानियां)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If a SCAR is not confirmed, VIJOICE may require dose modifications, topical or systemic corticosteroids, or oral antihistamine treatment as described in Table 4 [see Dosage and Administration (2.5)] . (एल्पेलिसिब लेबल, चेतावनियां और सावधानियां)

Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (एल्बेंडाज़ोल लेबल, चेतावनियां और सावधानियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ऑक्सीकोडोन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ऑक्सीकोडोन और पैरासिटामोल लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ऑक्सीमॉर्फोन लेबल, चेतावनियां और सावधानियां)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

In multiple sclerosis (MS) clinical trials, all adult and pediatric patients who were treated with OCREVUS received premedication with methylprednisolone (or an equivalent steroid), and may have also received an antihistamine (all pediatric patients) and/or an analgesic/antipyretic to reduce the risk of infusion reactions prior to each infusion. (ओक्रेलिज़ुमैब लेबल, चेतावनियां और सावधानियां)

The risk of developing fluoroquinolone-associated tendinitis and tendon rupture is increased in patients over 60 years of age, in those taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. (ओफ्लॉक्सासिन लेबल, चेतावनियां)

Corticosteroid Reduction: Do not abruptly discontinue corticosteroids upon initiation of OMLYCLO therapy. (ओमालिज़ुमैब लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ओलिसेरिडिन लेबल, चेतावनियां और सावधानियां)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Plasma cholinesterase activity may be decreased by chronic administration of certain monoamine oxidase inhibitors, oral contraceptives, glucocorticoids, antimyasthenics (neostigmine), cyclophosphamide, and possibly thiotepa. (कोकेन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (कोडीन लेबल, चेतावनियां और सावधानियां)

Cholestyramine Cholestyramine may increase the clearance of corticosteroids. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Prevention or Management Consider a possible decrease in cladribine efficacy if potent BCRP (e.g., corticosteroids) or P-gp (e.g., rifampicin, St. (क्लैड्रिबिन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Corticosteroids, valproic acid, or haloperidol : May increase plasma ammonia level; monitor ammonia levels closely. (ग्लिसरॉल फिनाइलब्यूटिरेट लेबल, दवाओं के इंटरैक्शन)

Prior to the first BIZENGRI infusion, premedicate with a corticosteroid, an H1 antihistamine and acetaminophen to reduce the risk of IRRs [see Dosage and Administration (2.4) ]. (ज़ेनोक्यूटुज़ुमैब लेबल, चेतावनियां और सावधानियां)

A dental examination with appropriate preventive dentistry should be considered prior to treatment with bisphosphonates in patients with a history of concomitant risk factors (e.g., cancer, chemotherapy, angiogenesis inhibitors, radiotherapy, corticosteroids, poor oral hygiene, preexisting dental disease or infection, anemia, coagulopathy). (ज़ोलेड्रोनिक एसिड लेबल, चेतावनियां और सावधानियां)

If the patient needs more doses of terbutaline sulfate tablets than usual, this may be a marker of destabilization of asthma and requires reevaluation of the patient and the treatment regimen, giving special consideration to the possible need for anti-inflammatory treatment, e.g., corticosteroids. (टरब्यूटालिन लेबल, चेतावनियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Concomitant Respiratory Medications SPIRIVA RESPIMAT has been used concomitantly with short-acting and long-acting sympathomimetic (beta-agonists) bronchodilators, methylxanthines, oral and inhaled steroids, antihistamines, mucolytics, leukotriene modifiers, cromones, and anti-IgE treatment without increases in adverse reactions. (टियोट्रोपियम लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (टेपेंटाडोल लेबल, चेतावनियां और सावधानियां)

Pneumocystis Pneumonia (PCP) : Closely monitor all patients, particularly those receiving steroids, for the development of lymphopenia and PCP. (टेमोज़ोलोमाइड लेबल, चेतावनियां और सावधानियां)

If ILD is suspected, discontinue TORISEL, and consider use of corticosteroids and/or antibiotics. (टेम्सिरोलिमस लेबल, चेतावनियां और सावधानियां)

Changes in thyroid status of the patient may necessitate adjustment in dosage. (प्रेडनिसोन लेबल, चेतावनियां और सावधानियां)

Glucocorticoids : Patients receiving glucocorticoid replacement for previously diagnosed hypoadrenalism may require an increase in maintenance or stress doses following initiation of EGRIFTA SV. (टेसामोरेलिन लेबल, दवाओं के इंटरैक्शन)

Abuse of Testosterone and Monitoring of Serum Testosterone : If testosterone use at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids is suspected, check serum testosterone concentration ( 5.5 ). (टेस्टोस्टेरोन लेबल, चेतावनियां और सावधानियां)

Mild or Moderate CYP3A Inducers Methylprednisolone, prednisone May decrease tacrolimus whole blood trough concentrations. (टैक्रोलिमस लेबल, दवाओं के इंटरैक्शन)

Corticosteroids and ACTH: Increased risk of hypokalemia. (टॉरसेमाइड लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ट्रामाडोल लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ट्रामाडोल और पैरासिटामोल लेबल, चेतावनियां और सावधानियां)

Other Considerations Concurrent use of hydrochlorothiazide with amphotericin B or corticosteroids or corticotropin (ACTH) may intensify electrolyte imbalance, particularly hypokalemia, although the presence of triamterene minimizes the hypokalemic effect. (ट्रायमटेरिन और हाइड्रोक्लोरोथायज़ाइड लेबल, दवाओं के इंटरैक्शन)

Interrupt TRAZIMERA infusion in all patients experiencing dyspnea, clinically significant hypotension, and intervention of medical therapy administered (which may include epinephrine, corticosteroids, diphenhydramine, bronchodilators, and oxygen). (ट्रैस्टुज़ुमैब लेबल, चेतावनियां और सावधानियां)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Anticholinergic drugs in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as corticosteroids. (डाइसाइक्लोमिन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Digitalis Patients on digitalis glycosides may be at increased risk of arrhythmias due to hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Eosinophilic Conditions: Be alert to vasculitic rash, worsening pulmonary symptoms, cardiac complications, kidney injury and/or neuropathy, especially upon reduction of oral corticosteroids. (डुपिलुमैब लेबल, चेतावनियां और सावधानियां)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Other risk factors for the development of ONJ include immunosuppressive therapy, treatment with angiogenesis inhibitors, systemic corticosteroids, diabetes, and gingival infections. (डेनोसुमैब लेबल, चेतावनियां और सावधानियां)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)

Anticoagulant agents: May enhance or diminish anticoagulant effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

…treated with 6-mercaptopurine (500 mg/m 2 intravenously daily for 5 days per cycle every 2–3 weeks) and doxorubicin hydrochloride (50 mg/m 2 intravenous once per cycle every 2–3 weeks) alone or with vincristine and prednisone, all developed hepatic dysfunction manifested by increased total serum bilirubin, alkaline phosphatase and aspartate aminotransferase. (डॉक्सोरूबिसिन लेबल, दवाओं के इंटरैक्शन)

…following drugs can be coadministered with dolutegravir without a dose adjustment: atazanavir/ritonavir, darunavir/ritonavir, elbasvir/grazoprevir, methadone, midazolam, omeprazole, oral contraceptives containing norgestimate and ethinyl estradiol, prednisone, rifabutin, rilpivirine, sofosbuvir/velpatasvir, and tenofovir [see Clinical Pharmacology ( 12.3 )] . (डोलुटेग्राविर लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Dosage Increases: Increases in the dose of theophylline should not be made in response to an acute exacerbation of symptoms of chronic lung disease since theophylline provides little added benefit to inhaled beta2 -selective agonists and systemically administered corticosteroids in this circumstance and increases the risk of adverse effects. (थियोफाइलिन लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (नालबुफिन लेबल, चेतावनियां)

…hypoglycemia concomitant administration of medications that may lower the seizure threshold, including other bupropion products, antipsychotics, tricyclic antidepressants, theophylline, systemic steroids Recommendations for Reducing the Risk of Seizure: Clinical experience with bupropion suggests that the risk of seizure may be minimized by adhering to the recommended… (नाल्ट्रेक्सोन और ब्यूप्रोपियॉन लेबल, चेतावनियां और सावधानियां)

Use OFEV with caution when treating patients with recent abdominal surgery, previous history of diverticular disease or receiving concomitant corticosteroids or NSAIDs. (निंटेडानिब लेबल, चेतावनियां और सावधानियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

In Studies MS1 and MS2, an increase in infections was seen in patients concurrently receiving short courses of corticosteroids. (नैटालिज़ुमैब लेबल, चेतावनियां और सावधानियां)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (पेंटाज़ोसिन और नालोक्सोन लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (पेथिडीन लेबल, चेतावनियां और सावधानियां)

Treatment has consisted of high doses of corticosteroids alone or, in some cases, concomitantly with an immunosuppressant. (पेनिसिलामिन लेबल, चेतावनियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Many of these patients were also receiving chemotherapy and corticosteroids, which may be risk factors for ONJ. (पैमिड्रोनेट लेबल, चेतावनियां और सावधानियां)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (पैरासिटामोल और कोडीन लेबल, चेतावनियां)

If adrenal insufficiency is suspected, it should be confirmed and treated per standard of care with exogenous glucocorticoids at replacement doses . (पैसिरियोटाइड लेबल, चेतावनियां और सावधानियां)

Prior and Concomitant Treatment with Anti-neoplastic, Immune-Modulating, or Immunosuppressive Therapies Anti-neoplastic, immune-modulating, or immunosuppressive therapies (including corticosteroids) should be coadministered with caution because of the risk of additive immune system effects [see Drug Interactions (7.1) ] . (पोनेसिमोड लेबल, चेतावनियां और सावधानियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Published animal studies show prednisolone to be teratogenic in rats, rabbits, hamsters, and mice with increased incidence of cleft palate in offspring. (प्रेडनिसोन लेबल, चेतावनियां और सावधानियां)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Changes in thyroid status of the patient may necessitate adjustment in dosage. (प्रेडनिसोन लेबल, चेतावनियां और सावधानियां)

The following appear to be major risk factors for the development of these events: decreased oxygen delivery to tissues; serious neurological injury and/or sepsis; high dosages of one or more of the following pharmacological agents: vasoconstrictors, steroids, inotropes and/or prolonged, high-dose infusions of propofol (> 5 mg/kg/hour for > 48 hours). (प्रोपोफोल लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (प्रोमेथाज़िन और कोडीन लेबल, चेतावनियां और सावधानियां)

In both cases, the patients were taking a 1.25 mg dose of fingolimod (higher than the recommended 0.5 mg dose) and had received high-dose corticosteroid therapy to treat suspected MS relapses. (फिंगोलिमोड लेबल, चेतावनियां और सावधानियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Agonistic Effects (increase in BIORPHEN blood pressure effect) can occur with monoamine oxidase inhibitors (MAOI), oxytocin and oxytocic drugs, tricyclic antidepressants, angiotensin and aldosterone, atropine, steroids, norepinephrine transporter inhibitors, ergot alkaloids. (फिनाइलएफ्रिन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (फेंटानिल लेबल, चेतावनियां और सावधानियां)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inducers (e.g., Barbiturates, Phenytoin, Carbamazepine, and Rifampin) Drugs such as barbiturates, phenytoin, ephedrine, and rifampin, which induce hepatic microsomal drug metabolizing enzyme activity may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Anticoagulant agents: May enhance or diminish anticoagulant effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Use of more than one corticosteroid-containing product at the same time may increase the total systemic absorption of topical corticosteroids. (फ्लुओसिनोनाइड लेबल, चेतावनियां और सावधानियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Prednisone reduction can be accomplished by reducing the daily prednisone dose by 2.5 mg on a weekly basis during therapy with Fluticasone Propionate DISKUS. (फ्लुटिकासोन लेबल, चेतावनियां और सावधानियां)

Hypercorticism and Adrenal Suppression Fluticasone propionate, a component of Fluticasone Propionate/Salmeterol MDPI, will often help control asthma symptoms with less suppression of HPA function than therapeutically equivalent oral doses of prednisone. (फ्लुटिकासोन और सैल्मेटेरोल लेबल, चेतावनियां और सावधानियां)

The use of flunisolide with alternate-day prednisone systemic treatment could increase the likelihood of HPA suppression compared to a therapeutic dose of either one alone. (फ्लुनिसोलाइड लेबल, चेतावनियां)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Corticosteroids (systemic): cortisone/hydrocortisone dexamethasone ↑ corticosteroids (systemic) ↓ lenacapavir (dexamethasone) Concomitant administration with systemic corticosteroids whose exposures are significantly increased by CYP3A inhibitors can increase the risk for Cushing's syndrome and adrenal suppression. (बिक्टेग्राविर, एमट्रिसिटाबिन और टेनोफोविर एलाफेनामाइड लेबल, दवाओं के इंटरैक्शन)

Anticoagulant agents: May enhance or diminish anticoagulant effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Prednisone reduction can be accomplished by reducing the daily prednisone dose by 2.5 mg on a weekly basis during therapy with PULMICORT FLEXHALER. (बुडेसोनाइड लेबल, चेतावनियां और सावधानियां)

Prednisone reduction can be accomplished by reducing the daily prednisone dose by 2.5 mg on a weekly basis during therapy with budesonide and formoterol fumarate dihydrate. (बुडेसोनाइड और फॉर्मोटेरोल लेबल, चेतावनियां और सावधानियां)

Consider measures to prevent severe reactions, including antihistamines, antipyretics and corticosteroids in subsequent cycles in patients who have experienced Grade 1 or 2 infusion reactions. (बेंडामुस्टिन लेबल, चेतावनियां और सावधानियां)

Hypercorticism and Adrenal Suppression QVAR REDIHALER will often help control asthma symptoms with less suppression of HPA function than therapeutically equivalent oral doses of prednisone. (बेक्लोमेथासोन लेबल, चेतावनियां और सावधानियां)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

• Reduction in Corticosteroid Dosage: Do not discontinue systemic or inhaled corticosteroids abruptly upon initiation of therapy with FASENRA. (बेनरालिज़ुमैब लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (बेलाडोना और ओपियम लेबल, चेतावनियां और सावधानियां)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inducers (e.g., Barbiturates, Phenytoin, Carbamazepine, and Rifampin) Drugs such as barbiturates, phenytoin, ephedrine, and rifampin, which induce hepatic microsomal drug metabolizing enzyme activity may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inducers (e.g., Barbiturates, Phenytoin, Carbamazepine, and Rifampin) Drugs such as barbiturates, phenytoin, ephedrine, and rifampin, which induce hepatic microsomal drug metabolizing enzyme activity may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inducers (e.g., Barbiturates, Phenytoin, Carbamazepine, and Rifampin) Drugs such as barbiturates, phenytoin, ephedrine, and rifampin, which induce hepatic microsomal drug metabolizing enzyme activity may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ब्यूटॉर्फेनॉल लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ब्यूप्रेनॉर्फिन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ब्यूप्रेनॉर्फिन और नालोक्सोन लेबल, चेतावनियां और सावधानियां)

…risk of seizure: concomitant use of other medications that lower the seizure threshold (e.g., other bupropion products, antipsychotics, tricyclic antidepressants, theophylline, and systemic corticosteroids), metabolic disorders (e.g., hypoglycemia, hyponatremia, severe hepatic impairment, and hypoxia), or use of illicit drugs (e.g., cocaine) or abuse or misuse… (ब्यूप्रोपियॉन लेबल, चेतावनियां और सावधानियां)

In a randomized comparative trial of mitoxantrone injection plus low-dose prednisone vs. low-dose prednisone, 7 of 128 patients (5.5 %) treated with mitoxantrone injection had a cardiac event defined as any decrease in LVEF below the normal range, congestive heart failure (n = 3), or myocardial ischemia. (माइटोक्सैंट्रोन लेबल, चेतावनियां)

In patients who experience mild or moderate IRRs, consider premedications, including antihistamines, corticosteroids, and antipyretics. (मार्गेटुक्सिमैब लेबल, चेतावनियां और सावधानियां)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids. (मिथाइलटेस्टोस्टेरोन लेबल, चेतावनियां)

If not, corticosteroids may be given and other causes of anemia should be considered. (मिथाइलडोपा लेबल, चेतावनियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

This can be corrected by giving appropriate doses of corticosteroids. (मेटाइरापोन लेबल, चेतावनियां और सावधानियां)

Corticosteroids Or ACTH May increase the risk of hypokalemia and increase salt and water retention. (मेटोलाज़ोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Drug Interactions Methazolamide should be used with caution in patients on steroid therapy because of the potential for developing hypokalemia. (मेथाज़ोलामाइड लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (मेथाडोन लेबल, चेतावनियां और सावधानियां)

Changes in thyroid status of the patient may necessitate adjustment in dosage. (प्रेडनिसोन लेबल, चेतावनियां और सावधानियां)

NSAIDs, Aspirin, and Steroids: May elevate and prolong serum methotrexate levels and increase gastrointestinal toxicity. (मेथोट्रेक्सेट लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inducers (e.g., Barbiturates, Phenytoin, Carbamazepine, and Rifampin) Drugs such as barbiturates, phenytoin, ephedrine, and rifampin, which induce hepatic microsomal drug metabolizing enzyme activity may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Decrease corticosteroids gradually, if appropriate. (मेपोलिज़ुमैब लेबल, चेतावनियां और सावधानियां)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

The risk of developing fluoroquinolone-associated tendinitis and tendon rupture is increased in patients over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. (मॉक्सीफ्लॉक्सासिन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (मॉर्फिन लेबल, चेतावनियां और सावधानियां)

Inhaled corticosteroid may be reduced gradually. (मोंटेलुकास्ट लेबल, चेतावनियां और सावधानियां)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Hypercorticism and Adrenal Suppression ASMANEX HFA will often help control asthma symptoms with less suppression of HPA function than therapeutically equivalent oral doses of prednisone. (मोमेटासोन लेबल, चेतावनियां और सावधानियां)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Anticoagulant agents: May enhance or diminish anticoagulant effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

…the jaw include invasive dental procedures (for example, tooth extraction, dental implants, boney surgery), diagnosis of cancer, concomitant therapies (for example, chemotherapy, corticosteroids, angiogenesis inhibitors), poor oral hygiene, and co-morbid disorders (for example, periodontal and/or other pre-existing dental disease, anemia, coagulopathy, infection,… (रिसेड्रोनेट लेबल, चेतावनियां और सावधानियां)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Therefore, for patients receiving both neuromuscular blocking agents (including Rocuronium Bromide Injection) and corticosteroids, the period of use of the neuromuscular blocking agent should be limited as much as possible and only used in the setting where in the opinion of the prescribing physician, the specific advantages of the drug outweigh the risk. (रोक्यूरोनियम लेबल, चेतावनियां और सावधानियां)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Changes in thyroid status of the patient may necessitate adjustment in dosage. (प्रेडनिसोन लेबल, चेतावनियां और सावधानियां)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Even in those instances where swelling of only the tongue is involved, without respiratory distress, patients may require prolonged observation since treatment with antihistamines and corticosteroids may not be sufficient. (लिसिनोप्रिल और हाइड्रोक्लोरोथायज़ाइड लेबल, चेतावनियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (लेवॉर्फेनॉल लेबल, चेतावनियां)

Changes in thyroid status of the patient may necessitate adjustment in dosage. (प्रेडनिसोन लेबल, चेतावनियां और सावधानियां)

Changes in thyroid status of the patient may necessitate adjustment in dosage. (प्रेडनिसोन लेबल, चेतावनियां और सावधानियां)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogens, Including Oral Contraceptives Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

The risk of developing fluoroquinolone-associated tendinitis and tendon rupture is increased in patients usually over 60 years of age, in those taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. (लेवोफ्लॉक्सासिन लेबल, चेतावनियां और सावधानियां)

If the patient needs more doses of XOPENEX HFA than usual, this may be a marker of destabilization of asthma and requires reevaluation of the patient and treatment regimen, giving special consideration to the possible need for anti-inflammatory treatment, e.g., corticosteroids. (लेवोसैल्बुटामोल लेबल, चेतावनियां और सावधानियां)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Anticoagulant agents: May enhance or diminish anticoagulant effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Oral Contraceptive Steroids Administration of a single-dose of ethinyloestradiol (50 mcg)/levonorgestrel (250 mcg) to 6 women on valproate (200 mg BID) therapy for 2 months did not reveal any pharmacokinetic interaction. (वैल्प्रोइक एसिड लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

The neuromuscular blocking effect of succinylcholine may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase [see Warnings and Precautions (5.9) ]. (सक्सिनिलकोलिन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Cyclosporine: Increase in activity of both, cyclosporine and corticosteroid when administered concurrently. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Drug Interactions Reversible decreases in steady-state plasma digoxin concentrations and renal glycoside excretion were observed in patients receiving beta-acetyldigoxin and chemotherapy regimens containing cyclophosphamide, vincristine and prednisone with or without cytarabine injection or procarbazine. (साइटाराबिन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Prednisone reduction can be accomplished by reducing the daily prednisone dose by 2.5 mg on a weekly basis during ALVESCO therapy [see Dosage and Administration ( 2 )] . (सिक्लेसोनाइड लेबल, चेतावनियां और सावधानियां)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

The risk of developing fluoroquinolone-associated tendinitis and tendon rupture is increased in patients over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. (सिप्रोफ्लॉक्सासिन लेबल, चेतावनियां और सावधानियां)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to increased risk of corticosteroid side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

CYP 3A4 inducers and inhibitors: May, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (सेफॉक्सिटिन लेबल, चेतावनियां और सावधानियां)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Antidiabetic agents: May increase blood glucose concentrations. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If the patient needs more doses of Albuterol Sulfate HFA than usual, this may be a marker of destabilization of asthma and requires reevaluation of the patient and treatment regimen, giving special consideration to the possible need for anti-inflammatory treatment, e.g., corticosteroids. (सैल्बुटामोल लेबल, चेतावनियां और सावधानियां)

Use of corticosteroids may cause a protein catabolic state and, thereby, potentially increase plasma ammonia levels in patients with impaired ability to form urea. (सोडियम फिनाइलएसीटेट और सोडियम बेंज़ोएट लेबल, दवाओं के इंटरैक्शन)

Valproic Acid, Haloperidol, or Corticosteroids : May increase plasma ammonia level; monitor ammonia levels closely. (सोडियम फिनाइलब्यूटिरेट लेबल, दवाओं के इंटरैक्शन)

Long-term treatment with steroids may be necessary (see PRECAUTIONS, Laboratory Tests ). (हाइड्रालाज़िन लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोकोडोन लेबल, चेतावनियां और सावधानियां)

NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोकोडोन और क्लोरफेनिरामिन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोकोडोन और पैरासिटामोल लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोकोडोन और होमाट्रोपिन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोमॉर्फोन लेबल, चेतावनियां और सावधानियां)

Anticoagulant agents: May enhance or diminish anticoagulant effects. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Caution is advised when haloperidol decanoate is used in combination with drugs known to cause electrolyte imbalance (e.g., diuretics or corticosteroids) because hypokalemia, hypomagnesemia, and hypocalcemia are risk factors for QT prolongation. (हेलोपेरिडोल लेबल, दवाओं के इंटरैक्शन)

Use of more than one corticosteroid-containing product at the same time may increase the total systemic exposure to topical corticosteroids. (हेलोबेटासोल लेबल, चेतावनियां और सावधानियां)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

ATROVENT HFA has been used concomitantly with other drugs, including sympathomimetic bronchodilators, methylxanthines, oral and inhaled steroids commonly used in the treatment of COPD. (इप्राट्रोपियम लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Patients improved with discontinuation of therapy and in certain cases administration of corticosteroids. (उस्टेकिनुमैब लेबल, चेतावनियां और सावधानियां)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Most patients with hypersensitivity pneumonitis discontinued treatment with ARIKAYCE and received treatment with corticosteroids [see Adverse Reactions (6.1) ] . (एमिकासिन लेबल, चेतावनियां और सावधानियां)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

OXYGEN, INTRAVENOUS STEROIDS, AND AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINISTERED AS INDICATED. (एम्पीसिलिन लेबल, चेतावनियां)

Drug/Laboratory Test Interactions Amphetamines can cause a significant elevation in plasma corticosteroid levels. (एम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

Interference with Laboratory Tests Amphetamines can cause a significant elevation in plasma corticosteroid levels. (एम्फेटामाइन और डेक्सट्रोएम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

If signs of hypersensitivity occur, e.g. anaphylactoid reaction or angioedema develops, discontinue the Activase infusion and promptly institute appropriate therapy (e.g., antihistamines, intravenous corticosteroids, epinephrine). (एल्टेप्लेज़ लेबल, चेतावनियां और सावधानियां)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

If an allergic reaction occurs, the drug should be discontinued and the patient should receive supportive treatment, e.g. , artificial maintenance of ventilation, pressor amines, antihistamines, and corticosteroids. (ऑक्सासिलिन लेबल, चेतावनियां)

Most patients improved promptly with discontinuation of fluoxetine and/or adjunctive treatment with antihistamines or steroids, and all patients experiencing these reactions were reported to recover completely. (ओलैंज़ापिन और फ्लुओक्सेटिन लेबल, चेतावनियां और सावधानियां)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Some subjects in the EPIDIOLEX clinical trials had pruritus, erythema, and angioedema requiring treatment, including corticosteroids and antihistamines. (कैनाबिडियोल (प्रिस्क्रिप्शन दवा) लेबल, चेतावनियां और सावधानियां)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (कैल्सिट्रिओल लेबल, दवाओं के इंटरैक्शन)

The recovery of the adrenal gland may take from days to months so patients should be protected from the stress (e.g., trauma or surgery) by the use of corticosteroids during the period of stress. (कॉर्टिकोट्रोपिन लेबल, चेतावनियां और सावधानियां)

The use of prophylactic steroids (e.g., 100 mg/m 2 hydrocortisone on Days 1 through 3) may be of benefit in preventing signs or symptoms of SIRS or capillary leak syndrome. (क्लोफाराबिन लेबल, चेतावनियां और सावधानियां)

Elevated urinary steroid levels, varying degrees of electrolyte imbalance, hypovolemia, hemoconcentration, and hypoproteinemia may occur. (क्लोमीफीन लेबल, चेतावनियां)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Drug/Laboratory Interactions Quinine may produce an elevated value for urinary 17-ketogenic steroids when the Zimmerman method is used. (क्विनीन लेबल, दवाओं के इंटरैक्शन)

TREMFYA was subsequently discontinued, and the liver test abnormalities resolved following administration of corticosteroids [see Adverse Reactions (6.1) ] . (गुसेलकुमैब लेबल, चेतावनियां और सावधानियां)

Anticholinesterase Agents Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

In the reported cases NME resolved with discontinuation of the glucagon, and treatment with corticosteroids was not effective. (ग्लूकागॉन लेबल, चेतावनियां और सावधानियां)

Most patients improved promptly with adjunctive treatment with antihistamines or steroids and/or upon discontinuation of ziprasidone, and all patients experiencing these reactions were reported to recover completely. (ज़िप्रासिडोन लेबल, चेतावनियां और सावधानियां)

If symptoms of hypersensitivity occur, initiate appropriate therapy (e.g., antihistamines, corticosteroids, epinephrine). (टेनेक्टेप्लेज़ लेबल, चेतावनियां और सावधानियां)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

In clinical studies, patients receiving TOBI Podhaler continued to take dornase alfa, bronchodilators, inhaled corticosteroids, and macrolides. (टोब्रामाइसिन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Fluid retention events were typically managed by supportive care measures that may include diuretics or short courses of steroids. (डासाटिनिब लेबल, चेतावनियां और सावधानियां)

Drug/Laboratory Test Interactions Amphetamines can cause a significant elevation in plasma corticosteroid levels. (डेक्सट्रोएम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

Anticholinesterase Agents Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

These would include diuretics, laxatives and supraphysiological use of steroid hormones with mineralocorticoid potential. (ड्रोपेरिडोल लेबल, दवाओं के इंटरैक्शन)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (नाल्ट्रेक्सोन लेबल, चेतावनियां और सावधानियां)

Moderate and weak CYP3A4 inducers include, for example: amprenavir, aprepitant, armodafinil, bosentan, efavirnenz, etravirine, Echinacea, modafinil, nafcillin, pioglitazone, prednisone, rufinamide, and vemurafenib. (निमोडिपिन लेबल, दवाओं के इंटरैक्शन)

Anticholinesterase Agents Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Anticholinesterase Agents Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

…performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren's efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone. (पाइलोकार्पिन लेबल, दवाओं के इंटरैक्शन)

Oxygen, intravenous steroids, and airway management, including intubation, should also be administered as indicated. (पेनिसिलिन G लेबल, चेतावनियां)

OXYGEN, INTRAVENOUS STEROIDS, AND AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINISTERED AS INDICATED. (पेनिसिलिन V लेबल, चेतावनियां)

Anticholinesterase Agents Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Most patients improved promptly with discontinuation of fluoxetine and/or adjunctive treatment with antihistamines or steroids, and all patients experiencing these reactions were reported to recover completely. (फ्लुओक्सेटिन लेबल, चेतावनियां और सावधानियां)

Steroids may or may not be effective in controlling these hemolytic episodes. (फ्लुडाराबिन लेबल, चेतावनियां और सावधानियां)

Since mineralocorticoid secretion may be impaired, salt and/or a mineralocorticoid should be administered concurrently. (प्रेडनिसोन लेबल, चेतावनियां और सावधानियां)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (बुसल्फान लेबल, चेतावनियां)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Tendon rupture may occur more frequently in patients over 60 years of age, in those taking corticosteroid or fluoroquinolone drugs, in patients with renal failure, and in patients with previous tendon disorders. (बेम्पेडोइक एसिड लेबल, चेतावनियां और सावधानियां)

Discontinue in patients who develop a severe infusion-related reaction and administer appropriate medical therapy (e.g., epinephrine, corticosteroids, intravenous antihistamines, bronchodilators and/or oxygen). (बेवासिज़ुमैब लेबल, चेतावनियां और सावधानियां)

…50,000/μL was required for study eligibility ‡ Data were missing at baseline for one patient In the combination study of bortezomib with rituximab, cyclophosphamide, doxorubicin and prednisone (BR-CAP) in previously untreated mantle cell lymphoma patients, the incidence of thrombocytopenia (≥ Grade 4) was 32% vs 1% for the rituximab, cyclophosphamide, doxorubicin,… (बोर्टेज़ोमिब लेबल, चेतावनियां और सावधानियां)

Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Drug/Laboratory Test Interactions Amphetamines can cause a significant elevation in plasma corticosteroid levels. (मेथएम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

Anticholinesterase Agents Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

The infusion should be terminated immediately, followed by the administration of volume expanders, pressor agents, corticosteroids, or antihistamines at the discretion of the physician. (मेलफलान लेबल, चेतावनियां)

Institute medical management (e.g., glucocorticoids, epinephrine, bronchodilators, or oxygen) for infusion-related reactions as needed. (रिटुक्सिमैब लेबल, चेतावनियां और सावधानियां)

Anticholinesterase Agents Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Other Concomitant Medications EVISTA can be concomitantly administered with ampicillin, amoxicillin, antacids, corticosteroids, and digoxin [see Clinical Pharmacology ( 12.3 )] . (रैलोक्सीफेन लेबल, दवाओं के इंटरैक्शन)

Patients with Grade 1 and 2 TFR may also be treated with corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs) and/or narcotic analgesics for management of TFR symptoms. (लेनालिडोमाइड लेबल, चेतावनियां और सावधानियां)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

प्रेडनिसोन जैसे कॉर्टिकोस्टेरॉइड कैल्शियम का अवशोषण कम करते हैं और विटामिन D के मेटाबॉलिज़्म को बिगाड़ते हैं, जिससे हड्डियों के क्षय में योगदान होता है। (NIH Office of Dietary Supplements, Vitamin D)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफडिनिर लेबल, चेतावनियां)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफप्रोज़िल लेबल, चेतावनियां)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफाक्लोर लेबल, चेतावनियां)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफाड्रोक्सिल लेबल, चेतावनियां और सावधानियां)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफोटेटन लेबल, चेतावनियां)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, IV FLUIDS, IV ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफ्टाज़िडिम लेबल, चेतावनियां)

Serious acute hypersensitivity reactions may require treatment with epinephrine and other emergency measures including oxygen, corticosteroids, intravenous fluids, intravenous antihistamines, pressor amines, and airway management, as clinically indicated. (सेफ्ट्रिएक्सोन लेबल, चेतावनियां और सावधानियां)

Sixteen (16) drugs tested did not show an in vitro interaction with LOKELMA (allopurinol, apixaban, aspirin, captopril, cyclosporine, digoxin, ethinyl estradiol, lisinopril, magnesium, metformin, phenytoin, prednisone, propranolol, quinapril, spironolactone and ticagrelor). (सोडियम ज़िरकोनियम साइक्लोसिलिकेट लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B Injection There have been cases reported in which concomitant use of Amphotericin B and hydrocortisone was followed by cardiac enlargement and congestive heart failure [see Drug Interactions (7.14) ] . (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (प्रेडनिसोन लेबल, दवाओं के इंटरैक्शन)

…influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline… (एमिनोफाइलिन लेबल, दवाओं के इंटरैक्शन)

Other Concomitant Drug Therapy Drug-drug interaction studies conducted in healthy subjects between zileuton immediate-release tablets and prednisone and ethinyl estradiol (oral contraceptive), drugs known to be metabolized by the CYP3A4 isoenzyme, have shown no significant interaction. (ज़ाइल्यूटॉन लेबल, दवाओं के इंटरैक्शन)